Edit |   |
---|---|
Product Name | Miglustat HCl (N-Butyldeoxynojirimycin) |
Description | Miglustat HCl (N-Butyldeoxynojirimycin) is a small molecule which can act as an a-Glucosidase inhibitor. It is provided as a powder. This product acts on the following target types: Glycosidase. This product acts on the following biochemical pathways: Carbohydrate metabolism, Sphingolipid metabolism. This product may be of interest in the following research areas and diseases: Neuroscience. This product may act as a Coronavirus inhibitor: Inhibits galactosidase alpha (GLA), which interacts with SARS-CoV-2 Nsp14; analog of IHVR-19029, and antiviral in clinical trials. Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. MW: 255.74 g/mol |
Size | 5 mg, 25 mg |
Concentration | n/a |
Applications | n/a |
Other Names | Miglustat HCl (N-Butyldeoxynojirimycin), N-Butyldeoxynojirimycin HCl, NB-DNJ, 210110-90-0 |
Gene, Accession, CAS # | CAS: 210110-90-0 |
Catalog # | abx282650 |
Price | please inquire |
Order / More Info | Miglustat HCl (N-Butyldeoxynojirimycin) from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950